Investors & VC Firms in Ireland

53 firms in this list, with a median first check of $1.1M. 5 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
LI Lightstone Ventures HPCGCICI22 people · Leads rounds	88🔒	Portola Valley	US	Pre-Seed–Late Stage	—	+ Add to CRM
AT Atlantic Bridge Ventures BLECGMHM11 people · Follows rounds	88🔒	Dublin	IE	Seed–Late Stage	$1M – $5M	+ Add to CRM
MO Motive Partners Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
SO SOSV CEMSPWPB8 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Series B	$30K – $550K	+ Add to CRM
FO Fountain Healthcare Partners AKMREPJL6 people · Leads rounds	88🔒	Dublin	IE	Seed–Series B	$10.8M – $16.2M	+ Add to CRM
FI Finch Capital AGFRMBRV9 people · Leads rounds	88🔒	Amsterdam	NL	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
AT Atomico NZAHBBCB11 people	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
AL Alchemy Partners LLP ADALDSIC11 people	88🔒	London	GB	Growth	$31.8M – $190.5M	+ Add to CRM
B2 b2venture FSAGCSGJ11 people	88🔒	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
EQ EQT Life Sciences APFVFAJR11 people	88🔒	Amsterdam	NL	Series A–Late Stage	$10.8M – $64.8M	+ Add to CRM
EU European Circular Bioeconomy Fund DSMAMBMN11 people	88🔒	Bonn	DE	Growth–Late Stage	$2.7M – $10.8M	+ Add to CRM
FO Foresight Group PECADWDH11 people	88🔒	Sydney Nsw	GB	Series A–Late Stage	$1.3M – $6.3M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
SC Schroders Greencoat BGLMMRMP11 people	88🔒	London	GB	Series A–Series B	$3.2M – $21.6M	+ Add to CRM
VE Verdane BKCJDAEJ11 people	88🔒	Oslo	NO	Growth	$21.6M – $162M	+ Add to CRM
MA Matterwave Ventures BKCRIKRG10 people	88🔒	Munich	DE	Seed–Series B	$1.1M – $10.8M	+ Add to CRM
SW Swisscom Ventures ASPLSKJM9 people	88🔒	Zürich	CH	Seed–Series B	$1M – $20M	+ Add to CRM
EU Eurazeo AACMESEL11 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
HE HealthCap AVAFBOCK11 people	88🔒	Stockholm	SE	Seed–Series A	—	+ Add to CRM
PA Panakes Partners ABDSFLBC11 people	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM
TH The Yield Lab Europe BCPFDBGG8 people	88🔒	Dublin	IE	Seed–Series A	$108K – $2.2M	+ Add to CRM
FE Ferocity Capital KVSWTM3 people	88🔒	—		—	—	+ Add to CRM
CR CRH Ventures ADMPBKCF10 people	88🔒	Madrid	US	Seed–Series A	—	+ Add to CRM
DE Development Capital ABSHACAD7 people	88🔒	Dublin	IE	Growth	$2.2M – $13M	+ Add to CRM

Lightstone Ventures

Portola ValleyPre-Seed–Late Stage

HPCGCICI22 people

Atlantic Bridge Ventures

DublinSeed–Late Stage$1M – $5M

BLECGMHM11 people

Motive Partners

New YorkPre-Seed–Late Stage$1M – $10M

SOSV

San FranciscoPre-Seed–Series B$30K – $550K

CEMSPWPB8 people

Fountain Healthcare Partners

DublinSeed–Series B$10.8M – $16.2M

AKMREPJL6 people

Finch Capital

AmsterdamSeries A–Growth$5.4M – $16.2M

AGFRMBRV9 people

Atomico

LondonSeed–Late Stage

NZAHBBCB11 people

Alchemy Partners LLP

LondonGrowth$31.8M – $190.5M

ADALDSIC11 people

b2venture

BerlinPre-Seed–Late Stage$270K – $5.4M

FSAGCSGJ11 people

EQT Life Sciences

AmsterdamSeries A–Late Stage$10.8M – $64.8M

APFVFAJR11 people

European Circular Bioeconomy Fund

BonnGrowth–Late Stage$2.7M – $10.8M

DSMAMBMN11 people

Foresight Group

Sydney NswSeries A–Late Stage$1.3M – $6.3M

PECADWDH11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Schroders Greencoat

LondonSeries A–Series B$3.2M – $21.6M

BGLMMRMP11 people

Verdane

OsloGrowth$21.6M – $162M

BKCJDAEJ11 people

Matterwave Ventures

MunichSeed–Series B$1.1M – $10.8M

BKCRIKRG10 people

Swisscom Ventures

ZürichSeed–Series B$1M – $20M

ASPLSKJM9 people

Eurazeo

ParisSeries A–Late Stage

AACMESEL11 people

HealthCap

StockholmSeed–Series A

AVAFBOCK11 people

Panakes Partners

MilanSeed–Late Stage

ABDSFLBC11 people

The Yield Lab Europe

DublinSeed–Series A$108K – $2.2M

BCPFDBGG8 people

Ferocity Capital

KVSWTM3 people

CRH Ventures

MadridSeed–Series A

ADMPBKCF10 people

Development Capital

DublinGrowth$2.2M – $13M

ABSHACAD7 people

Data sourced from public filings and firms' own websites — see our methodology.